HomeNewsIndiaThree cases of BA.4 and 1 of BA.5 Omicron sub-variants of coronavirus found in Mumbai

Three cases of BA.4 and 1 of BA.5 Omicron sub-variants of coronavirus found in Mumbai

The Maharashtra health department said on Monday that three individuals with BA.4 and one with BA.5 Omicron sub-variants of coronavirus were detected in Mumbai and that all of them had recovered from the infection.

June 13, 2022 / 19:16 IST
Story continues below Advertisement
 (Image: Reuters)
(Image: Reuters)

Three patients of BA.4 and one of BA.5 Omicron sub-variants of coronavirus have been found in Mumbai and all of them have already recovered from the infection, the Maharashtra health department said on Monday.

BA.4 and BA.5 are sub-variants of the highly transmissible Omicron strain of the coronavirus which had triggered the third wave of the pandemic in the country.

Story continues below Advertisement

The health department said a report of civic-run Kasturba Hospital's laboratory confirmed the presence of BA.4 sub-lineage in three patients and BA.5 sub-variant in one patient in the metropolis.Out of the four patients, two were girls aged 11 and two men in the 40 to 60 age group, it said.

"All these patients have recovered under home isolation," the department stated.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show
PTI
first published: Jun 13, 2022 07:16 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!